News

Wall Street expects a year-over-year increase in earnings on higher revenues when IQVIA Holdings (IQV) reports results for the quarter ended September 2025. While this widely-known consensus

Wall Street expects a year-over-year increase in earnings on higher revenues when ATI (ATI) reports results for the quarter ended September 2025. While this widely-known consensus outlook is

The market expects Visa (V) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook is

A.O. Smith (AOS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook

The market expects Herc Holdings (HRI) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus

Interpublic Group (IPG) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus

Group 1 Automotive (GPI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus

Intel Corporation INTC is scheduled to report third-quarter 2025 earnings after the closing bell on Oct. 23. In the to-be-reported quarter, the company is likely to have recorded higher revenues

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Oct. 21:

Verastem, Inc. VSTM: This biopharmaceutical company has a Zacks Rank #1 and

Shares of Liquidia Technologies, Inc. (LQDA) have gained 6.7% over the past four weeks to close the last trading session at $24.44, but there could still be a solid upside left in the stock if

Shares of Monopar Therapeutics Inc. (MNPR) have gained 21.2% over the past four weeks to close the last trading session at $77.15, but there could still be a solid upside left in the stock if

Shares of HIVE Digital Technologies (HIVE) have gained 46.3% over the past four weeks to close the last trading session at $5.59, but there could still be a solid upside left in the stock if

Shares of Bank7 (BSVN) have been struggling lately and have lost 7.1% over the past two weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock

CorMedix (CRMD) closed the last trading session at $12.16, gaining 7.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

After reaching an important support level, Allegiant Travel Company (ALGT) could be a good stock pick from a technical perspective. ALGT recently experienced a "golden cross" event, which saw its

Alkermes (ALKS) closed the last trading session at $30.98, gaining 12.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

A downtrend has been apparent in HeartSciences Inc. (HSCS) lately. While the stock has lost 8.3% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was formed in

Teva Pharmaceutical Industries Ltd. (TEVA) closed the last trading session at $19.42, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

The fragile ceasefire in Gaza, which took effect on Oct. 10, 2025, faced its most serious test over the past weekend, as a resurgence of violence put the conflict back in the global spotlight. This

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research